ABL Life Insurance Enhances “(Non-participating) WooriWON Children’s Insurance” with 16 New Riders

On May 8, ABL Life Insurance announced the upgraded launch of its “(Non-participating) WooriWON Children’s Insurance (no surrender value payment type)” in celebration of Family Month in May. The product offers broad coverage, ranging from sudden accidents that may occur to children to high-cost illnesses such as cancer.

The “(Non-participating) WooriWON Children’s Insurance (no surrender value payment type)” allows policyholders to choose between two types of coverage: Type 1, which provides accident disability benefits, and Type 2, which provides general cancer diagnosis benefits. This enables parents to focus on the coverage that best matches their child’s needs.

By adding optional riders, the product offers extensive, daily-life-focused protection for conditions commonly experienced during infancy and childhood, such as atopic dermatitis, chickenpox, strabismus, and dental diseases. It also provides broad coverage for major illnesses, including cancer, cerebrovascular disease, benign brain tumors, and ischemic heart disease, supporting children’s healthy growth. In addition, it covers safety-related incidents such as burns, fractures and cast treatments, traffic accidents, and emergency room visits, helping children vulnerable to unexpected accidents prepare with peace of mind.

In particular, the upgraded product adds a total of 16 new riders to the existing “(Non-participating) WooriWON Children’s Insurance (no surrender value payment type),” enhancing coverage for major illnesses and daily-life-focused protection that children may need.

Eligibility for enrollment ranges from fetuses and newborns (age 0) up to age 15. The premium payment period can be set from 5 to 30 years, and the coverage period can be designed to last up to age 100.

Kim Soonjae, Head of Product Division at ABL Life Insurance, said, “This product was developed as a customized children’s insurance policy in response to growing social interest in child safety accidents and pediatric cancer, so that families can be prepared even for situations requiring long-term and repeated outpatient treatments. We plan to continue introducing differentiated products tailored to customers’ life cycles in the future.”

This content was produced with the assistance of AI translation services.